Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary

András Harsányi,Marcell Csanádi,Kristóf Márky,Áron Zoltán Vincziczki,Zoltán Kaló,András Inotai

Influence of biosimilar infliximab launch on the utilization pattern of biological medicines: the case of Hungary

2019

András Harsányi
Marcell Csanádi
Kristóf Márky
Áron Zoltán Vincziczki
Zoltán Kaló
András Inotai

ABSTRACTObjectives: Utilization of multisource biological (off-patent originator and its biosimilar) medicines can improve the efficiency of resource allocation by 1) generating savings while maint...

Keywords:

Infliximab
Biosimilar
Resource allocation
Drug Utilization
Intensive care medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations